摘要
目的探讨不同治疗方案治疗小儿腹泻的临床效果。方法选取小儿腹泻患者220例,随机分为对照组107例,观察组113例,对照组患儿在常规治疗基础上加用蒙脱石散口服,观察组患儿在对照组基础上加用枯草杆菌二联活菌多维颗粒剂口服。对两组患者的治疗时间、治疗效果以及不良反应进行比较。结果观察组患儿止泻时间、纠正脱水时间、平均治愈时间以及治疗总疗程明显短于对照组(P<0.05)。观察组患儿痊愈率和总有效率分别为82.30%和98.23%,对照组分别为53.27%和87.85%,观察组明显高于对照组(P<0.05)。观察组不良反应发生率为66.37%,对照组为62.62%,两组差异无统计学意义(P>0.05)。结论在蒙脱石散的基础上联合应用枯草杆菌二联活菌多维颗粒剂治疗小儿腹泻,可以提高患儿的治疗效果,缩短治疗时间,安全、方便、有效。
Objective To observe the clinical effect of different therapeutic schedules in the treatment of children di- arrhea.Methods 220 cases of patients with children diarrhea were selected and divided into two groups randomly,the control group for 107 cases and the observation group for 113 cases.The control group were treated with montmorillonite powder on the basis of the conventional treatment,and the observation group were treated with united viable bacillus subtilis two dimensional granules on the basis of the control group.The treatment time,treatment effect and adverse re- actions of two groups was compared.Results The antidiarrheal time,correct dehydration time,average healing time and the overall course of the observation group was evidently shorter than that of the control group (P〈0.05).The cure rate and the total effective rate of the observation group was 82.30% and 98.23%,and that of the control group was 53.27% and 87.85%,the observation group was evidently better than that of the control group (P〈0.OS).The incidence of adverse reaction in observation group was 66.37%,the control group was 62.62%,the difference was not significant (P〉O.05). Conclusion Using united viable bacillus subtilis two dimensional granules on the basis of montmorillonite powder to treat children diarrhea can improve the treatment effect,shorten the treatment time,is safe,convenient and effective~
出处
《中国当代医药》
2014年第2期54-55,58,共3页
China Modern Medicine
关键词
蒙脱石散
枯草杆菌二联活菌多维颗粒剂
儿童
腹泻
Montmorillonite powder
United viable bacillus subtilis two dimensional granules
Children
Diarrhea